In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

Google has pulled its AI Overviews from several health-related search queries after an investigation found the summaries ...

The overall response rate (ORR) is 35%; this increases to 42% when including unconfirmed responses Narmafotinib continues to be well tolerated by patients with the adverse effect profile of the ...

Revolution Medicines surged on AbbVie buyout rumors but pulled back after denial. Learn what's next for RVMD stock and why it ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...